Descrizione Clinica
Prostate Pelvilen dual act 20cpr
pellets
Dual Act
Description
Chronic pelvic pain associated with numerous pathologies of the pelvic area (endometriosis, interstitial cystitis, recurring cystitis, chronic prostatitis, irritable colon syndrome, etc.) is a nosological entity with dual location, resulting in neuro-inflammation phenomena supported by non neuronal cells (matocyte, microglia). The woven localization, linked to peripheral sensitization due to the sensory terminations of nerves that co-innerate different pelvic organs, determines the share of diffuse inflammatory pain and associated oxidative stress. Spinal localization, instead linked to the central sensitization insorted due to the chronicity of the peripheral neuro-inflammatory phenomenon, determines and sustains the share of neuropathic pain that amplifies the algic feeling felt by the patient.
Pelvilen Dual Act is able to intervene effectively on both components of pain (mixed pain) through a synergistic and synchronous adjustment effect exercised by palmitoilethanolamide in the two forms, micronized and ultra-micronized. The contemporary presence of polydatin, a polyphenol with high antioxidant activity, allows the control of oxidative stress associated with neuro-inflammation in pelvic tissues.
Ingredients
Palmitoiletanolamide-polidatin informs co-micronized (particle size 2.0-10.0 micron), palmitoilethanolamide ultra micronized (particle size 0.8-6.0 micron); emulsifiers: microcrystalline cellulose, fatty acid magnesium salts, vegetable polysorbate, E1521; stabilizers: croscarmellose sodium, polyvinylpyrrolidone, polyvinylalcool; anti agglomerants: silicon dioxide, talc; dyes: E132, E171, E172.
Without gluten.
Nutritional characteristics
Mode of use
Pelvilen Dual Act, in the two different formulations (microgranules for sublingual use and tablets), must be used under medical supervision. We recommend taking the following modes:
-Pelvilen Dual Act microgranules, preferably assumed by sublingual means, on an online medical indication 1-2 sachets per day for cycles of at least 10 days, possibly repeated.
-Pelvilen Dual Act tablets, on online medical indication 1-2 tablets daily for cycles of 20-30 days, possibly repeated.
Warnings
Use under medical control.
Products cannot be the only source of nutrition.
Keep away from the reach of children under 3 years.
We do not recommend the use of pregnant products.
Conservation
Store at room temperature.
Validity of whole packaging36 months.
Format
Blister from 20 tablets.
Cod. 8026
Chronic pelvic pain associated with numerous pathologies of the pelvic area (endometriosis, interstitial cystitis, recurring cystitis, chronic prostatitis, irritable colon syndrome, etc.) is a nosological entity with dual location, resulting in neuro-inflammation phenomena supported by non neuronal cells (matocyte, microglia). The woven localization, linked to peripheral sensitization due to the sensory terminations of nerves that co-innerate different pelvic organs, determines the share of diffuse inflammatory pain and associated oxidative stress. Spinal localization, instead linked to the central sensitization insorted due to the chronicity of the peripheral neuro-inflammatory phenomenon, determines and sustains the share of neuropathic pain that amplifies the algic feeling felt by the patient.
Pelvilen Dual Act is able to intervene effectively on both components of pain (mixed pain) through a synergistic and synchronous adjustment effect exercised by palmitoilethanolamide in the two forms, micronized and ultra-micronized. The contemporary presence of polydatin, a polyphenol with high antioxidant activity, allows the control of oxidative stress associated with neuro-inflammation in pelvic tissues.
Ingredients
Palmitoiletanolamide-polidatin informs co-micronized (particle size 2.0-10.0 micron), palmitoilethanolamide ultra micronized (particle size 0.8-6.0 micron); emulsifiers: microcrystalline cellulose, fatty acid magnesium salts, vegetable polysorbate, E1521; stabilizers: croscarmellose sodium, polyvinylpyrrolidone, polyvinylalcool; anti agglomerants: silicon dioxide, talc; dyes: E132, E171, E172.
Without gluten.
Nutritional characteristics
| Average values | for 1 tablet | for 100 g |
| Energy | 7,13 kcal 29.9 kJ | 631 kcal 2.642 kJ |
| Protein | ||
| Carbohydrate of which sugar | ||
| Fats of which saturated | 0,79 g 0,68 g | 70,0 g 60,0 g |
| Food fibres | 0.20 g | 17,5 g |
| Rooms | 0.014 g | 1,25 g |
| Palmitoilethanolamide | 0,800 g | 70.8 g |
| Polida | 0.040 g | 3.54 g |
Mode of use
Pelvilen Dual Act, in the two different formulations (microgranules for sublingual use and tablets), must be used under medical supervision. We recommend taking the following modes:
-Pelvilen Dual Act microgranules, preferably assumed by sublingual means, on an online medical indication 1-2 sachets per day for cycles of at least 10 days, possibly repeated.
-Pelvilen Dual Act tablets, on online medical indication 1-2 tablets daily for cycles of 20-30 days, possibly repeated.
Warnings
Use under medical control.
Products cannot be the only source of nutrition.
Keep away from the reach of children under 3 years.
We do not recommend the use of pregnant products.
Conservation
Store at room temperature.
Validity of whole packaging36 months.
Format
Blister from 20 tablets.
Cod. 8026
